Bio-Techne Corporation (TECH)

Revenue by Geography

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013	Jun 30, 2012
United States Revenue	645.66M	683.23M	657.75M
United States Revenue Growth	-5.50%	3.87%	2.38%
EMEA ex-UK Revenue	284.28M	266.31M	241.43M
EMEA ex-UK Revenue Growth	6.75%	10.30%	9.63%
United Kingdom Revenue	56.61M	54.83M	50.01M
United Kingdom Revenue Growth	3.26%	9.63%	1.12%
APAC ex-Greater China Revenue	82.60M	77.26M	73.90M
APAC ex-Greater China Revenue Growth	6.90%	4.54%	0.98%
Greater China Revenue	104.05M	100.46M	99.47M
Greater China Revenue Growth	3.57%	1.00%	-12.65%
Rest of World Revenue	37.61M	37.55M	36.50M
Rest of World Revenue Growth	0.17%	2.87%	-2.65%
Revenue (Other)	-2.00K	5.00K	-
Revenue (Total)	1.21B	1.22B	1.16B
Revenue (Total) Growth	-0.72%	5.23%	1.97%

Revenue

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013	Jun 30, 2012
Protein Sciences Revenue	869.90M	870.25M	830.90M
Protein Sciences Revenue Growth	-0.04%	4.74%	-1.75%
Diagnostics and Genomics Revenue	335.93M	346.26M	326.39M
Diagnostics and Genomics Revenue Growth	-2.98%	6.09%	11.55%
Other Segment Revenue	-	4.15M	4.15M
Other Segment Revenue Growth	-	-0.02%	-
Intersegment Revenue	-455.00K	-1.03M	-2.39M
Revenue (Other)	5.44M	5.00K	-
Revenue (Total)	1.21B	1.22B	1.16B
Revenue (Total) Growth	-0.72%	5.23%	1.97%

EBIT

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013	Jun 30, 2012
Protein Sciences Operating Income	361.12M	370.35M	354.78M
Protein Sciences Operating Income Growth	-2.49%	4.39%	-5.06%
Diagnostics and Genomics Operating Income	33.01M	21.32M	24.55M
Diagnostics and Genomics Operating Income Growth	54.82%	-13.13%	-42.96%
Operating Income (Total)	153.75M	102.26M	206.69M
Operating Income (Total) Growth	50.36%	-50.53%	-30.86%

Key Performance Indicators

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013	Jun 30, 2012
Organic Sales Growth	5.00%	1.00%

Data Source: Fiscal.ai Last updated: May 6, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 24, 2026

Data Sources Report a data error